Status:
UNKNOWN
Interactions of Medicine and Exercise With Meal Timing
Lead Sponsor:
University of Castilla-La Mancha
Collaborating Sponsors:
Ministerio de Economía y Competitividad, Spain
Servicio de Salud de Castilla-La Mancha
Conditions:
Metabolic Syndrome, Protection Against
Exercise Training
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
To analyze the effects of altering the time of ingestion of participants' habitual medication (i.e., metformin, statins, ARAII/IACE) and meals around the time of exercise training (exercise fasted or ...
Detailed Description
Objective: The purpose is to study in a group of adults with metabolic syndrome and obesity, the effects of altering timing between exercise training, meals, and their habitual medication on the impro...
Eligibility Criteria
Inclusion
- Metabolic syndrome patients diagnosed according to The International diabetes federation consensus of 2009 (Alberti, et al., Circulation).
Exclusion
- Cardiovascular disease or musculo-skeletal that prevents them from being able to perform intense exercise.
- Respiratory failure
- Liver o renal disease
- Pregnancy
Key Trial Info
Start Date :
June 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04477590
Start Date
June 7 2022
End Date
December 30 2024
Last Update
August 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Castilla-La Mancha (Exercise Physiology Lab)
Toledo, Spain, 45071